Total Payments
$1,602
2024 Payments
$149.88
Companies
14
Transactions
87
Payment Breakdown by Category
Food & Beverage$1,602 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,602 | 87 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $656.53 | 40 | $0 (2021) |
| ABBVIE INC. | $312.51 | 19 | $0 (2023) |
| Adlon Therapeutics L.P. | $202.55 | 9 | $0 (2021) |
| IDORSIA PHARMACEUTICALS US INC | $120.86 | 1 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $113.71 | 6 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $54.69 | 3 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $40.34 | 2 | $0 (2018) |
| Ironshore Pharmaceuticals Inc. | $18.58 | 1 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $15.85 | 1 | $0 (2017) |
| Lundbeck LLC | $14.93 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $149.88 | 3 | IDORSIA PHARMACEUTICALS US INC ($120.86) |
| 2023 | $92.23 | 5 | Supernus Pharmaceuticals, Inc. ($56.18) |
| 2022 | $222.60 | 13 | ABBVIE INC. ($194.09) |
| 2021 | $192.12 | 10 | Adlon Therapeutics L.P. ($90.38) |
| 2020 | $308.57 | 21 | Allergan, Inc. ($196.40) |
| 2019 | $127.50 | 7 | Allergan Inc. ($82.20) |
| 2018 | $288.54 | 18 | Allergan Inc. ($227.59) |
| 2017 | $220.46 | 10 | Allergan Inc. ($130.97) |
All Payment Transactions
87 individual payment records from CMS Open Payments — Page 2 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/18/2021 | Adlon Therapeutics L.P. | ADHANSIA XR (Drug) | Food and Beverage | Cash or cash equivalent | $20.32 | General |
| Category: PRESCRIPTION STIMULANT | ||||||
| 03/22/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: NEUROSCIENCE | ||||||
| 03/17/2021 | Adlon Therapeutics L.P. | ADHANSIA XR (Drug) | Food and Beverage | Cash or cash equivalent | $24.72 | General |
| Category: PRESCRIPTION STIMULANT | ||||||
| 01/26/2021 | Adlon Therapeutics L.P. | ADHANSIA XR (Drug) | Food and Beverage | Cash or cash equivalent | $24.07 | General |
| Category: PRESCRIPTION STIMULANT | ||||||
| 01/08/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: NEUROSCIENCE | ||||||
| 01/05/2021 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: NEUROSCIENCE | ||||||
| 12/30/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: NEUROSCIENCE | ||||||
| 11/24/2020 | Adlon Therapeutics L.P. | ADHANSIA XR (Drug) | Food and Beverage | Cash or cash equivalent | $24.60 | General |
| Category: PRESCRIPTION STIMULANT | ||||||
| 11/16/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2020 | Adlon Therapeutics L.P. | ADHANSIA XR (Drug) | Food and Beverage | Cash or cash equivalent | $24.98 | General |
| Category: PRESCRIPTION STIMULANT | ||||||
| 09/08/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: NEUROSCIENCE | ||||||
| 09/02/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: NEUROSCIENCE | ||||||
| 07/07/2020 | Adlon Therapeutics L.P. | ADHANSIA XR (Drug) | Food and Beverage | Cash or cash equivalent | $23.80 | General |
| Category: PRESCRIPTION STIMULANT | ||||||
| 06/03/2020 | Adlon Therapeutics L.P. | ADHANSIA XR (Drug) | Food and Beverage | Cash or cash equivalent | $19.50 | General |
| Category: PRESCRIPTION STIMULANT | ||||||
| 05/26/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: NEUROSCIENCE | ||||||
| 05/19/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.68 | General |
| Category: NEUROSCIENCE | ||||||
| 05/19/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.90 | General |
| Category: NEUROSCIENCE | ||||||
| 05/06/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.62 | General |
| Category: NEUROSCIENCE | ||||||
| 05/05/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.59 | General |
| Category: NEUROSCIENCE | ||||||
| 05/05/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.45 | General |
| Category: NEUROSCIENCE | ||||||
| 03/04/2020 | Adlon Therapeutics L.P. | ADHANSIA XR (Drug) | Food and Beverage | Cash or cash equivalent | $19.29 | General |
| Category: PRESCRIPTION STIMULANT | ||||||
| 02/11/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: NEUROSCIENCE | ||||||
| 02/04/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.15 | General |
| Category: NEUROSCIENCE | ||||||
About Dr. Paul Reardon, M.D
Dr. Paul Reardon, M.D is a Psychiatry healthcare provider based in Newport Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1396951828.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Reardon, M.D has received a total of $1,602 in payments from pharmaceutical and medical device companies, with $149.88 received in 2024. These payments were reported across 87 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,602).
Ad
Practice Information
- Specialty Psychiatry
- Location Newport Beach, CA
- Active Since 05/14/2007
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1396951828
Products in Payments
- VRAYLAR (Drug) $969.04
- ADHANSIA XR (Drug) $202.55
- QUVIVIQ (Drug) $120.86
- QELBREE (Drug) $84.69
- REXULTI (Drug) $69.62
- Trintellix (Drug) $51.47
- Qelbree (Drug) $29.02
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $18.58
- BELSOMRA (Drug) $15.85
- Evekeo ODT (Drug) $14.36
- NUPLAZID (Drug) $13.50
- WELLBUTRIN (Drug) $12.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Newport Beach
Dr. Nader Oskooilar, Md, MD
Psychiatry — Payments: $321,179
Psychiatry $321,179
Dr. Hadi Estakhri, M.d, M.D
Psychiatry — Payments: $16,721
Psychiatry $16,721
Dr. Venice Sanchez, M.d, M.D
Psychiatry — Payments: $16,294
Psychiatry $16,294
Dr. Hisham Korraa, M.d, M.D
Psychiatry — Payments: $14,252
Psychiatry $14,252
Dr. Stefani Lafrenierre, Md, MD
Psychiatry — Payments: $7,842
Psychiatry $7,842
Nimisha Jain, Pa, PA
Psychiatry — Payments: $6,289
Psychiatry $6,289